---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-083088"
form_type: "8-K"
ticker: "CGON"
cik: "0001991792"
company_name: "CG Oncology, Inc."
filed_at: "2025-06-06T23:59:59+00:00"
generated_at: "2026-05-19T18:47:33.317275+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# CG Oncology stockholders elect three Class I directors, ratify EY as auditor at 2025 annual meeting

## Summary
- Arthur Kuan, James J. Mulé, Leonard Post elected as Class I directors to serve until 2028 annual meeting.
- Ratification of Ernst & Young as independent auditor for fiscal year ending Dec 31, 2025 was approved with 69.7M votes for, 7K against.
- Broker non-votes of 8.45M shares on director elections; no broker non-votes on auditor ratification.

## SEC filing metadata
- accession: 0000950170-25-083088
- form_type: 8-K
- ticker: CGON
- cik: 0001991792
- company_name: CG Oncology, Inc.
- filed_at: 2025-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1991792/000095017025083088/0000950170-25-083088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1991792/000095017025083088/ck0001991792-20250605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-083088
- JSON: https://secwatch.observer/filing/0000950170-25-083088.json
- Plain text: https://secwatch.observer/filing/0000950170-25-083088.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.